Search Results

The GPCR Data Dilemma: The Lego Bucket Problem I've seen promising GPCR programs generate massive volumes Systems That Drive Progress:  From assay tracking to data workflows, I design simple, scalable tools GPCR As the co-founder of Dr. GPCR, we've built a global hub connecting over 1,300 GPCR scientists dedicated to this field. Ready to Move Your GPCR Program Forward?

Read the article now ➤ Discovery on Target - The Next Wave of GPCR Drug Discovery The 20th Annual GPCR-Based Drug Discovery Conference  isn’t just another event—it’s where the frameworks shaping the next decade GPCR Premium Membership Gives You an Edge The GPCR field is advancing at breakneck speed. The pace of GPCR innovation is accelerating. Aside from his vast experience in drug development, not to mention his extensive publication record,

content — designed to keep you ahead without noise or delays: Industry insights:  Structure-Based Drug Design Summit; AI-Powered GPCR Research; Lab-in-the-Loop Hit Discovery advances. Must-read publications:  GPCRchimeraDB: Database of engineered GPCR designs. lectures, classified industry news, priority event alerts, job opportunities, and insider commentary—all designed GPCR Premium is designed for scientists who need the right intelligence, fast—without noise, distractions

Explore Martin Marro’s impact on GPCR drug discovery, assay innovation, and translational pharmacology , Bias, and Translational Drug Discovery This episode features Dr. How advanced assay design is essential for translating cell-based GPCR signals to therapeutic outcomes drug discovery. How integrating antibody-based modalities has expanded options for hard-to-drug GPCR targets.

GPCR unites researchers, industry, and partners to accelerate GPCR science and drug discovery—through GPCR Ecosystem We unite the GPCR community to advance drug discovery. We bring the GPCR community together to fuel GPCR drug discovery—one receptor at a time. Contact Us Our Mission Advance GPCR science and drug discovery by connecting people, data, and opportunities across the global GPCR ecosystem.

function The NTF Release Sensor Approach for Drug Discovery for Human Adhesion GPCRs Stephanie Häfner Discovery for Human Adhesion GPCRs Stephanie Häfner Abstract "G Protein-coupled receptors (GPCRs) are common drug targets, yet no approved drugs exist for the Adhesion G Protein-coupled receptors (aGPCRs drug discovery methods. This tailored system aims to expedite the identification of drugs targeting the unique aGPCR receptor